National Research Corporation Becomes Certified for ACO

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
National Research Corporation Becomes Certified for ACO CAHPS

LINCOLN, Neb., Oct. 24, 2013 (GLOBE NEWSWIRE) -- As part of the Patient Protection and Affordable Care Act, National Research Corporation is pleased to announce its approval by the Centers for Medicaid and Medicare Services (CMS) as a CAHPS® survey provider for Accountable Care Organizations (ACOs). The approval is contingent upon successful completion of CMS training, which will be completed in October.

CMS created three programs for ACOs through its Innovation Center (Pioneer ACO Model, Medicare Shared Savings Program, and Advance Payment ACO Model) and all are intended to reduce healthcare costs. The three programs are required to participate in quality measures, including the ACO CAHPS survey. ACOs are responsible for contracting with an approved vendor, such as National Research, to administer the survey beginning in 2014.
ACOs are groups of doctors, hospitals, and other healthcare providers, who come together voluntarily to give coordinated, high-quality care to Medicare patients. The ACO CAHPS survey measures the patient experience for accountable care organizations and also assesses specific measures included in the Medicare Shared Savings Program and Pioneer ACO Model.

In addition, National Research announces its certification for the Medicare Advantage – Prescription Drug Plan (MA-PDP) CAHPS Survey. This survey is an initiative to assess patient experience among beneficiaries of Medicare Advantage plans. CMS requires all MA and PDP contracts with more than 600 enrollees to contract with an approved vendor. National Research will also begin surveying MA-PDP CAHPS next year.

"We are very excited to continue offering new CAHPS surveys that meet the evolving needs of the healthcare profession," said Susan L. Henricks, president and chief operating officer at National Research. "It's important we help the efforts of accountable care organizations to support delivering high-quality, patient-centered care."

About National Research Corporation

For more than 30 years, National Research Corporation (NASDAQ: NRCIA and NRCIB) has been at the forefront of patient-centered care. Today, the company's focus on empowering customer-centric healthcare across the continuum extends patient-centered care to incorporate families, communities, employees, senior housing residents, and other stakeholders.

Recognized by Modern Healthcare as one of the largest patient satisfaction firms in the U.S., National Research is dedicated to representing the true voice of patients and other healthcare stakeholders. This integration of cross-continuum metrics and analytics uncovers insights for effective performance improvement, quality measurement, care transitions, and many other factors that impact population health management.

National Research is headquartered in Lincoln, Nebraska. For more information, call 800-388-4264, write to info@nationalresearch.com, or visit www.nationalresearch.com .

Scott Smith Director of Marketing National Research Corporation 800-388-4264

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Fnac Darty Reports Share Buyback Transactions for June 2025

Updated Category News Views 243

Fnac Darty's Own Share Transactions Overview Recently, the renowned retail group Fnac Darty disclosed its trading activities involving shares from June 23 to June 27, 2025. This announcement is part of its continued commitment to transparency in its financial operations and shareholder communications. Significance of Share Buybacks Buyback programs are strategic moves for...

Continue Reading
Reboot Studios Announces Innovative Jewish Media Projects for 2024

Updated Category News Views 273

Reboot Studios Unveils Exciting Jewish Media Projects for 2024 A New Chapter in Jewish Storytelling Reboot Studios, which is dedicated to empowering creators and artists, has announced the projects that will be part of its 2024 Creator Fund lineup. This latest funding round builds on previous achievements, including the Oscar-shortlisted dark comedy The Anne Frank Gift...

Continue Reading
Sigrid Therapeutics Advances Diabetes Management with SiPore® Food

Updated Category News Views 244

Innovative Access to SiPore® Technology Sigrid Therapeutics is thrilled to share that it has successfully secured U.S. market access for its groundbreaking SiPore® technology following the impressive results from the SHINE study, which is recognized as the largest study of its kind in prediabetes. About the SHINE Study The SHINE study provided pivotal insights into the...

Continue Reading
Strategic Investment by Cordatus Capital in Red Dot Buildings

Updated Category News Views 865

Cordatus Capital's Strategic Move to Partner with Red Dot Buildings Cordatus Capital is thrilled to announce a significant majority investment in Red Dot Buildings, a pioneering manufacturer of complex metal building systems. This partnership marks a premier opportunity for both Cordatus and Red Dot to leverage their strengths and drive substantial growth. Red Dot is...

Continue Reading
Class Action Alerts: Opportunities for LULU, F, XPEL, and EXTR Investors

Updated Category News Views 107

Understanding Recent Class Action Lawsuits for Major Companies Investors often find themselves unsure about how corporate decisions might affect their finances. Recently, a number of well-known companies have been caught up in class action lawsuits, which can have serious implications for shareholders. It's important for investors to grasp their legal position and explore...

Continue Reading